The current status and future of ADC therapy for small cell Lung Cancer: a promising approach

Among the subset of 9 patients, a remarkable response rate of 77.8% was observed, with 7 patients showing partial responses (PRs). [...]ADCs offer a promising and rapidly evolving therapeutic strategy for the treatment of SCLC. Continued research and development efforts in these areas are expected t...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 21; no. 1; pp. 1 - 808
Main Authors Zhou, Jiawei, Ma, Peiwen, Tang, Qiyu, Wang, Shuhang, Li, Ning
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 13.11.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Among the subset of 9 patients, a remarkable response rate of 77.8% was observed, with 7 patients showing partial responses (PRs). [...]ADCs offer a promising and rapidly evolving therapeutic strategy for the treatment of SCLC. Continued research and development efforts in these areas are expected to further improve the efficacy and safety of ADCs, ultimately benefiting patients with SCLC in clinical practice.
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:1479-5876
1479-5876
DOI:10.1186/s12967-023-04471-2